Literature DB >> 24529933

Utilization of radial artery access for percutaneous coronary intervention for ST-segment elevation myocardial infarction in New York.

Edward L Hannan1, Louise Szypulski Farrell2, Gary Walford3, Peter B Berger4, Nicholas J Stamato5, Ferdinand J Venditti6, Alice K Jacobs7, David R Holmes8, Samin Sharma9, Spencer B King10.   

Abstract

OBJECTIVES: This study sought to determine the utilization and outcomes for radial access for percutaneous coronary intervention (PCI) for ST-segment elevation acute myocardial infarction (STEMI) in common practice.
BACKGROUND: Radial access for PCI has been studied considerably, but mostly in clinical trials.
METHODS: All patients undergoing PCI for STEMI in 2009 to 2010 in New York were studied to determine the frequency and the patient-level predictors of radial access. Differences in in-hospital/30-day mortality between radial and femoral access were also studied.
RESULTS: Radial access increased from 4.9% in the first quarter of 2009 to 11.9% in the last quarter of 2010. Significant independent predictors were higher body surface area, non-Hispanic ethnicity, Caucasian race, stable hemodynamic state, ejection fraction <30% and ≥50% onset of STEMI from 12 to 23 h before the index procedure, and peripheral vascular disease. Mortality was not related to access site after adjustment for covariates (for radial vs. femoral access, adjusted odds ratio: 0.86, 95% confidence interval: 0.59 to 1.25), but the radial access site was trending toward lower mortality for the 9 hospitals that used it for more than 10% of their patients (adjusted odds ratio: 0.61, 95% confidence interval: 0.36 to 1.02).
CONCLUSIONS: The use of a radial access site for PCI in STEMI patients increased between 2009 and 2010, but was still infrequent in 2010, and was used for lower-risk STEMI patients. There was no significant difference in mortality by access site, but there was a trend toward a mortality advantage for patients with a radial access site among hospitals that used it relatively frequently.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PCI; STEMI; radial access

Mesh:

Year:  2014        PMID: 24529933     DOI: 10.1016/j.jcin.2013.10.020

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  5 in total

Review 1.  Transradial intervention in ST elevation myocardial infarction.

Authors:  Ahmad H S Mustafa; Eric Holroyd; Rob Butler; Doug Fraser; Magdi El-Omar; James Nolan; Mamas A Mamas
Journal:  Curr Cardiol Rep       Date:  2015-05       Impact factor: 2.931

2.  Increased pulse wave transit time after percutaneous coronary intervention procedure in CAD patients.

Authors:  Lizhen Ji; Chengyu Liu; Peng Li; Xinpei Wang; Changchun Liu; Yinglong Hou
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

3.  The effect of milrinone on mortality in adult patients who underwent CABG surgery: a systematic review of randomized clinical trials with a meta-analysis and trial sequential analysis.

Authors:  Yu-Shan Ren; Lan-Fang Li; Tao Peng; Yu-Jun Tan; Ying Sun; Guo-Liang Cheng; Gui-Min Zhang; Jie Li
Journal:  BMC Cardiovasc Disord       Date:  2020-07-08       Impact factor: 2.298

4.  Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients.

Authors:  Salma Taha; Fabrizio D'Ascenzo; Claudio Moretti; Pierluigi Omedè; Antonio Montefusco; Richard G Bach; Karen P Alexander; Roxana Mehran; Albert Ariza-Solé; Giuseppe Biondi Zoccai; Fiorenzo Gaita
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-09-28       Impact factor: 1.426

5.  Reversing the "Risk-Treatment Paradox" of Bleeding in Patients Undergoing Percutaneous Coronary Intervention: Risk-Concordant Use of Bleeding Avoidance Strategies Is Associated With Reduced Bleeding and Lower Costs.

Authors:  Amit P Amin; Samantha Miller; Brandon Rahn; Mary Caruso; Andrew Pierce; Katrine Sorensen; Howard Kurz; Alan Zajarias; Richard Bach; Jasvindar Singh; John M Lasala; Hemant Kulkarni; Patricia Crimmins-Reda
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.